Cerebras Files $3.5B IPO That Could Hit $26.6B Valuation on OpenAI Tailwind

Cerebras Systems filed an amended S-1 on Monday that lifts its IPO target to $3.5 billion and sets the price range at $115–125 per share for 28 million shares. Reuters says the move would value the Sunnyvale company at $26.6 billion, up from the $23 billion figure circulating in February. CNBC notes the range implies a market cap of $24.5 billion on the low end, still above the last private mark. Proceeds will fund wafer-scale cluster build-outs and cloud capacity ahead of a flood of new AI training and inference demand.

Because Cerebras sells entire 8.5-inch silicon wafers as single chips, 46,225 mm² versus Nvidia’s 814 mm² H100, its architecture removes the inter-GPU networking bottleneck that has forced most labs into proprietary stacks. The company already ships CS-3 systems with 900 MB on-chip memory, meaning open-source PyTorch models can run unchanged at near-linear scaling. If the IPO succeeds, expect a wave of open-source wafer-scale kernels and benchmarks as researchers gain access to a hardware path that isn’t locked behind CUDA.

OpenAI’s January $10 billion, 750 MW multi-year supply agreement is the key proof point Cerebras is showing investors. According to AI Business, the deal runs through 2028 and covers inference as well as training. OpenAI has already released a model specifically optimized for Cerebras silicon, signaling a strategic hedge against Nvidia shortages. Threads and social chatter put the total potential value at $20 billion when renewals and future phases are included. That revenue pipeline alone covers a large chunk of the IPO raise, making the S-1 look more like a pre-order book than a speculative bet.

Amazon Web Services is planning to deploy Cerebras alongside Trainium in select regions, according to unconfirmed posts circulating on Threads. If true, AWS would become the first hyperscaler to offer wafer-scale instances, pressuring Google and Microsoft to accelerate their own custom silicon roadmaps. AMD, Broadcom, and Intel are also watching closely: Cerebras is proving that extreme monolithic dies can command premium pricing if the software stack is clean. The IPO success would validate a radically different scaling law, die size over process node, that incumbents have mostly dismissed.

Trading is expected to start later this month under ticker symbol CBRS. The greenshoe option could push total proceeds past $4 billion. Lock-up expiries in 180 days will coincide with first-quarter 2027 earnings, giving early insight into OpenAI ramp rates. Road-show feedback suggests institutional demand is already 3× oversubscribed, according to MLQ. If the deal prices at the top, Cerebras will leapfrog AMD’s market cap and plant a flag for wafer-scale architecture as a first-class citizen in the AI hardware wars.